American Addiction Centers: The For-Profit Rehab Chain the DOJ Says Billed for Treatment It Did Not Deliver

American Addiction Centers Inc., one of the largest for-profit substance use disorder treatment companies in the United States, faced Department of Justice scrutiny under the False Claims Act after federal investigators and whistleblowers documented billing practices at the company's residential and outpatient treatment facilities that included claims for therapy sessions that did not occur as billed, group counseling attributed to licensed professionals who were not present for the sessions, and upcoded service levels that did not correspond to the treatment actually delivered.DOCUMENTED

The allegations placed American Addiction Centers in a pattern of scrutiny that the DOJ has directed at the for-profit substance use disorder treatment sector broadly — an area where federal and state billing fraud enforcement has intensified as addiction treatment spending through government health programs has grown substantially following expanded insurance coverage mandates and the ongoing opioid epidemic.

How Substance Use Disorder Billing Fraud Operates

Billing fraud in the substance use disorder treatment sector exploits the complexity of addiction treatment service codes and the difficulty government health programs face in verifying the specifics of clinical encounters at residential facilities. Treatment for substance use disorders is billed through a set of procedure codes that differentiate based on the type of service — individual therapy, group therapy, medication-assisted treatment, assessment, case management — and by the credential of the provider delivering it. A session billed as individual therapy with a licensed clinical social worker generates a different reimbursement than the same session delivered by a certified counselor or documented as group therapy.REVIEWED

Fraudulent billing in this context typically involves one of several patterns: billing for individual sessions that did not occur, billing group sessions as individual sessions to collect the higher reimbursement, attributing sessions to licensed clinicians who were not present when the service was delivered or whose license was used to support the billing without their knowledge, or billing for the number of sessions contracted rather than the number actually delivered. All of these patterns result in payment by government health programs for services that were not provided as billed — a straightforward False Claims Act violation that the DOJ pursues both civilly and, in egregious cases, criminally.DOCUMENTED

The For-Profit Treatment Sector Context

American Addiction Centers represents the publicly traded, institutional end of the substance use disorder treatment market — a sector that ranges from small independent outpatient programs to large residential treatment chains with facilities across multiple states. The company's scale — dozens of facilities, thousands of patients — created both the volume of billing activity that made large-scale fraud possible and the internal coordination challenges that can make consistent compliance difficult to maintain across a geographically dispersed operation.REVIEWED

The for-profit addiction treatment sector has attracted sustained DOJ attention not only because of billing fraud but also because of patient brokering — the practice of paying for referrals of insured patients, which violates the anti-kickback statute — and because of treatment quality concerns at facilities that census pressure may push toward admitting patients they cannot adequately treat. The False Claims Act enforcement context is distinct from these other issues but overlaps with them operationally: facilities under pressure to maintain census may bill aggressively for services to maximize revenue per patient, creating the conditions under which billing fraud occurs.

Billing for a therapy session that did not happen is not a documentation error. For a patient struggling with addiction, it is also a failure to deliver care that was supposed to be paid for and provided.

Whistleblowers and the Qui Tam Process

The investigation of American Addiction Centers, like many False Claims Act cases in the healthcare sector, was substantially driven by whistleblower complaints from former employees — counselors, billing staff, and facility administrators who had observed the billing practices and filed qui tam complaints with the DOJ under the False Claims Act's relator provisions. Qui tam whistleblowers who file original complaints can receive between 15 and 30 percent of any recovery the government obtains, creating a financial incentive for insiders with knowledge of billing fraud to bring it to the DOJ's attention.DOCUMENTED

The relator provisions of the False Claims Act have been among the most productive enforcement tools in healthcare fraud cases, generating a substantial portion of the DOJ's annual healthcare fraud recoveries. For employees at substance use disorder facilities who witness billing practices they believe violate federal law, the combination of financial recovery potential and whistleblower protections — which prohibit retaliation against qui tam relators — makes the False Claims Act complaint pathway a meaningful option that does not require the employee to first contact regulators or exhaust internal reporting channels.

Patient and Public Health Implications

The harm from billing fraud at substance use disorder treatment facilities is not purely financial. When a facility bills for sessions that did not occur, it has also failed to provide treatment that patients needed. In the context of substance use disorder — where relapse rates are high, treatment engagement is fragile, and the quality and consistency of clinical care have documented relationships to outcomes — sessions that were billed but not delivered represent gaps in treatment that can have consequences for individual patients beyond the financial harm to government health programs. Enforcement against billing fraud in this sector serves the dual purpose of protecting federal health program funds and ensuring that facilities are actually delivering the treatment they are paid to provide.

The Stakes for Patients in Billing Fraud Enforcement

The practical stakes for patients in addiction treatment billing fraud cases extend beyond the financial dimensions of the False Claims Act. When a treatment facility bills for sessions that did not occur, it has simultaneously failed to provide treatment that the billing represented was being delivered. In the context of substance use disorder — where treatment continuity, consistent therapeutic relationships, and adherence to evidence-based protocols all have documented relationships to recovery outcomes — gaps between billed and delivered services represent treatment failures with real consequences for individual patients. Patients who believe they are receiving a certain number of therapeutic sessions per week, and whose families are being billed accordingly, may not have visibility into whether those sessions actually occurred. Enforcement that holds billing fraud accountable in the substance use disorder sector therefore serves both the financial integrity of government health programs and the treatment quality interests of patients who depend on accurate service delivery from the facilities they trust with their care during what is often the most difficult period of their lives.

Have documents relevant to this story? Reach us through our tips channel.